Low birth weight and early hypoxemic respiratory failure impact neurodevelopment and survival

Article

The study also examined whether exposure to inhaled nitric oxide improved the outcomes for African American infants who had early hypoxemic respiratory failure.

An extremely low birth weight can be linked with many less than optimal outcomes in life. A report in Pediatrics examines whether extremely low birth weight combined with early hypoxemic respiratory failure to impact survival and neurodevelopmental impairment in young children aged 18 to 26 months.1

The study also examined whether exposure to inhaled nitric oxide improved the outcomes for African American infants who had early hypoxemic respiratory failure.

The researchers used the Neonatal Research Network to find infants who had a weight ≤ 1000g, had a gestational age ≤ 26 weeks, had maximal oxygen ≥ 60% on either day 1 or day 3, were labeled early hypoxemic respiratory failure, and were born between 2007 to 2015. They used a propensity score regression model to analyze the outcomes.

There were 7639 infants with extremely low birth weight who were born ≤ 26 weeks. In this group, 22.7% of the infants had early hypoxemic respiratory failure. The investigators found that early hypoxemic respiratory failure was linked with a mortality of 51.3%.

They also found the incidence of moderate-to-severe neurodevelopmental impairment was 41.2% in infants at 18 to 26 months of age. Among the infants who were treated with inhaled nitric oxide, the mortality was found to be 59.4%. Intact survival was linked to a complete course of antenatal steroids (adjusted odds ratio [aOR]: 1.6, 95% CI: 1.1–2.2), being female (aOR: 2.4, 95% CI: 1.8–3.3), and having a birth weight ≥ 720 g. Infants who were African American were found to have a similar incidence of early hypoxemic respiratory failure, 21.7% versus 23.3%.

However, they were found to have lower exposure to inhaled nitric oxide, 16.4% versus 21.6%. Intact survival, which meant no death or neurodevelopmental impairment, had no significant difference between African-American infants and other races (aOR: 1.5, 95% CI: 0.6–3.6), when looking at infants with hypoxemic respiratory failure who were exposed to inhaled nitric oxide.

The researchers concluded that early hypoxemic respiratory failure in infants with ≤ 26 weeks is linked with both high mortality and high neurodevelopment impairment at 18 to 26 years.

Additionally, the use of inhaled nitric oxide was not found to decrease either mortality or neurodevelopment and those outcomes were not different among African American infants.

This article was originally published in Contemporary Pediatrics.

Reference

1. Chandrasekharan P, Lakshminrusimha S, Chowdhury D, et al. Early hypoxic respiratory failure in extreme prematurity: mortality and neurodevelopmental outcomes. Pediatrics. September 17, 2020. Epub ahead of print. doi:10.1542/peds.2019-3318

Related Videos
Addressing maternal health inequities: Insights from CDC's Wanda Barfield | Image Credit: cdc.gov
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit: shrinerschildrens.org
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit:  uofmhealth.org.
The impact of smoking cessation on pregnancy outcomes | Image Credit: rwjmg.rwjms.rutgers.edu
Maximizing maternal health: The impact of exercise during pregnancy | Image Credit: cedars-sinai.org
The importance of nipocalimab’s FTD against FNAIT | Image Credit:  linkedin.com
Fertility treatment challenges for Muslim women during fasting holidays | Image Credit: rmanetwork.com
CDC estimates of maternal mortality found overestimated | Image Credit: rwjms.rutgers.edu.
Study unveils maternal mortality tracking trends | Image Credit: obhg.com
Related Content
© 2024 MJH Life Sciences

All rights reserved.